Trials / Completed
CompletedNCT03441217
Hyoscine Butylbromide Effect on Duration of Labor
Hyoscine Butylbromide Effect on Duration of Labor in Nulliparous Women: A Randomized, Double Blind, Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 218 (actual)
- Sponsor
- Saint Thomas Hospital, Panama · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the duration of labour (active phase of labour) in nulliparous women with gestations between 37 and 41 6/7 weeks when 20 mg of Hyoscine butylbromide was applied intravenously and compared with similar patients that received a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyoscine Butylbromide 20Mg/1mL Injection | Nulliparous women with gestations at term receive 20 mg of Hyoscine butylbromide upon arrival in the Labor and Delivery Unit (4-5 cms). |
| DRUG | Saline Solution | Nulliparous women with gestations at term receive 20 mg of saline solution upon arrival in the Labor and Delivery Unit (4-5 cms). |
Timeline
- Start date
- 2019-07-12
- Primary completion
- 2019-08-30
- Completion
- 2019-11-30
- First posted
- 2018-02-22
- Last updated
- 2019-12-06
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT03441217. Inclusion in this directory is not an endorsement.